Medical transcription technology provider Abridge has emerged from stealth with seed and series A funding.
Abridge, a US-based medical care advisory service, launched on Monday with $15m in seed and series A funding from investors including UPMC Enterprises, the investment arm of University of Pittsburgh Medical Center (UPMC).
Venture capital firm Union Square Ventures led both rounds, and the other participants included VC firms Bessemer Venture Partners, Pillar and KdT Ventures and an angel syndicate comprised of Esther Dyson, Aneesh Chopra and Zen Chu.
Abridge has developed software that provides users with a transcript of conversations they have had with doctors, using machine learning to highlight crucial definitions from a list of more than 400,000 terms in addition to instructions on self-care or medication.
The money will be used to grow the company’s team and improve its product and machine learning technology.
– A version of this article first appeared on our sister site, Global Corporate Venturing.
